Ironwood Pharmaceuticals, Inc. provided earnings guidance for the fiscal year 2024. For the fiscal year 2024, the company expected total revenue of $435 million - $455 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.82 USD | -3.22% | -1.26% | -31.64% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.64% | 1.24B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IRWD Stock
- News Ironwood Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc. Provides Earnings Guidance for the Fiscal Year 2024